Literature DB >> 33751410

Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019.

Gery P Guy1, Andrea E Strahan2, Tamara Haegerich2, Jan L Losby2, Kathleen Ragan2, Mary E Evans2, Christopher M Jones3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33751410      PMCID： PMC8481420          DOI： 10.1007/s11606-021-06662-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  7 in total

1.  Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.

Authors:  Christopher M Jones; Wilson Compton; Meena Vythilingam; Brett Giroir
Journal:  JAMA       Date:  2019-08-06       Impact factor: 56.272

2.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

3.  Legal requirements and recommendations to prescribe naloxone.

Authors:  Rebecca L Haffajee; Samantha Cherney; Rosanna Smart
Journal:  Drug Alcohol Depend       Date:  2020-02-06       Impact factor: 4.492

4.  Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Authors:  Ingrid A Binswanger; Stephen Koester; Shane R Mueller; Edward M Gardner; Kristin Goddard; Jason M Glanz
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

5.  Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco.

Authors:  Emily Behar; Christopher Rowe; Glenn-Milo Santos; Nina Santos; Phillip O Coffin
Journal:  Fam Med       Date:  2017-02       Impact factor: 1.756

6.  Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.

Authors:  Gery P Guy; Tamara M Haegerich; Mary E Evans; Jan L Losby; Randall Young; Christopher M Jones
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-08-09       Impact factor: 17.586

7.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.

Authors:  Christine L Mattson; Lauren J Tanz; Kelly Quinn; Mbabazi Kariisa; Priyam Patel; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-12       Impact factor: 17.586
  7 in total
  4 in total

1.  Opioid Prescribing to US Children and Young Adults in 2019.

Authors:  Kao-Ping Chua; Chad M Brummett; Rena M Conti; Amy S Bohnert
Journal:  Pediatrics       Date:  2021-08-16       Impact factor: 9.703

2.  Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.

Authors:  Christopher Dunphy; Kun Zhang; Gery P Guy; Christopher M Jones
Journal:  Prev Med       Date:  2021-09-29       Impact factor: 4.637

3.  Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.

Authors:  Kelly Quinn; Sagar Kumar; Calli T Hunter; Julie O'Donnell; Nicole L Davis
Journal:  Drug Alcohol Depend       Date:  2022-04-16       Impact factor: 4.852

4.  Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018.

Authors:  Evan D Peet; David Powell; Rosalie Liccardo Pacula
Journal:  JAMA Health Forum       Date:  2022-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.